Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition.

C Bunck, Mathijs; Diamant, Michaela; Eliasson, Bjorn; Cornér, Anja; M Shaginian, Rimma; J Heine, Robert; Taskinen, Marja-Riitta; Yki-Järvinen, Hannele; Smith, Ulf

doi:10.2337/dc09-2361

Public

Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition.

Shared by NobleBlocks on Aug 1, 2010 • 12:00 AM UTC

Authors:

Mathijs C Bunck

Michaela Diamant

Bjorn Eliasson

Abstract

OBJECTIVE: To study the effect of exenatide on body composition and circulating cardiovascular risk biomarkers. RESEARCH DESIGN AND METHODS: Metformin-treated patients with type 2 diabetes (N = 69) were randomized to exenatide or insulin glargine and treated for 1 year. Body composition was evaluate...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!